With a view toward improving coast to coast coverage with OCT technology, FYidoctors announced a substantial purchase from Carl Zeiss Canada’s Medical Division.
Dr. Alan Ulsifer, CEO and President of FYidoctors indicates, “the purchase is …a big part of our brand”.
In the statement, Moosah Gulam, Vice President at Carl Zeiss Canada, welcomed the choice of FYidoctors.
The OCT purchase builds upon previously announced collaborations between ZEISS and FYidoctors. Last November FYi became the first external laboratory in Canada authorized to manufacture Zeiss lenses. FYidoctors also uses i.Terminal 2.